Dexcom Warns of Stolen or Scrapped G7 Sensors Being Resold

Dexcom has discovered two lots of stolen or scrapped G7 sensors being sold to the public. The company has reached out to potentially impacted users to notify them of the affected products. This situation may pose a risk to customers' health.

Dexcom discovered that two lots of its G7 sensors were being sold to customers despite being stolen or scrapped. The company took immediate action to address the issue by notifying potentially affected users. To date, it appears that these stolen or scrapped sensors have made their way into the public market.

As a diabetes management device provider, the safety and reliability of its products are paramount to Dexcom. The recent incident underscores the risks associated with counterfeit or third-party resold medical devices, which could pose serious health risks to customers.

Dexcom's swift response and customer communication demonstrate a proactive approach to product safety.

Related Stocks

DXCM